120 related articles for article (PubMed ID: 71913)
1. Hydroxyethyl starch. An agent for hypovolaemic schock treatment II. Urinary excretion in normal volunteers following three consecutive daily infusions.
Mishler JM; Borberg H; Emerson PM; Gross R
Br J Clin Pharmacol; 1977 Oct; 4(5):591-5. PubMed ID: 71913
[TBL] [Abstract][Full Text] [Related]
2. Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.
Mishler JM; Ricketts CR; Parkhouse EJ
Br J Clin Pharmacol; 1979 May; 7(5):505-9. PubMed ID: 89855
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion kinetics of hydroxyethyl starch 350/0.60 in normovolaemic man.
Mishler JM; Ricketts CR; Parkhouse EJ
J Clin Pathol; 1981 Apr; 34(4):361-5. PubMed ID: 6165740
[TBL] [Abstract][Full Text] [Related]
4. Serial infusion effects of hydroxyethyl starch on ESR, blood typing and crossmatching and serum amylase levels.
Janes AW; Mishler JM; Lowes B
Vox Sang; 1977; 32(3):131-4. PubMed ID: 67712
[TBL] [Abstract][Full Text] [Related]
5. Macroamylasaemia following the infusion of low molecular weight-hydroxyethyl starch in man.
Mishler JM; Dürr HK
Eur Surg Res; 1979; 11(4):217-22. PubMed ID: 93539
[TBL] [Abstract][Full Text] [Related]
6. Intravascular persistence of hydroxyethyl starch in man.
Boon JC; Jesch F; Ring J; Messmer K
Eur Surg Res; 1976; 8(6):497-503. PubMed ID: 65282
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers.
Waitzinger J; Bepperling F; Pabst G; Opitz J
Drugs R D; 2003; 4(3):149-57. PubMed ID: 12757400
[TBL] [Abstract][Full Text] [Related]
8. Anaphylactoid reactions due to hydroxyethyl starch infusion.
Ring J; Seifert J; Messmer K; Brendel W
Eur Surg Res; 1976; 8(5):389-99. PubMed ID: 62664
[TBL] [Abstract][Full Text] [Related]
9. Transfusion of hydroxyethylated amylopectin-protected frozen blood in man. I. Plasma clearance and renal excretion of the cryoprotectant.
Mishler JM; Parry ES
Vox Sang; 1979; 36(6):337-41. PubMed ID: 91262
[TBL] [Abstract][Full Text] [Related]
10. [Intravascular persistence, tissue storage and excretion of hydroxyethyl starch (HAS)].
Thompson WL; Fukushima T; Rutherford RB; Walton RP
Infusionsther Klin Ernahr; 1979 Jun; 6(3):151-5. PubMed ID: 88413
[TBL] [Abstract][Full Text] [Related]
11. [Mathematical decription of the human intravascular elimination of HAS after repeated infusions].
Mishler JM; Beez M
Infusionsther Klin Ernahr; 1979 Apr; 6(2):119-22. PubMed ID: 85606
[TBL] [Abstract][Full Text] [Related]
12. Intestinal elimination of hydroxyethyl starch?
Lenz K; Schimetta W; Pölz W; Kröll W; Gruy-Kapral C; Magometschnigg D
Intensive Care Med; 2000 Jun; 26(6):733-9. PubMed ID: 10945391
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of hydroxyethyl starch in normal subjects.
Yacobi A; Stoll RG; Sum CY; Lai CM; Gupta SD; Hulse JD
J Clin Pharmacol; 1982 Apr; 22(4):206-12. PubMed ID: 6178760
[TBL] [Abstract][Full Text] [Related]
14. Macroamylasaemia after treatment with hydroxyethyl starch.
Köhler H; Kirch W; Weihrauch TR; Prellwitz W; Horstmann HJ
Eur J Clin Invest; 1977 Jun; 7(3):205-11. PubMed ID: 70354
[TBL] [Abstract][Full Text] [Related]
15. [Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].
Köhler H; Kirch W; Pitz H
Klin Wochenschr; 1978 Oct; 56(19):977-83. PubMed ID: 81905
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence comparison between hydroxyethyl starch 130/0.42/6 : 1 and hydroxyethyl starch 130/0.4/9 : 1.
Lehmann G; Marx G; Förster H
Drugs R D; 2007; 8(4):229-40. PubMed ID: 17596109
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyethyl starch: an agent for hypovolemic shock treatment.
Mishler JM; Borberg H; Emerson PM; Gross R
J Surg Res; 1977 Oct; 23(4):239-45. PubMed ID: 70572
[No Abstract] [Full Text] [Related]
18. A clinical study of low molecular weight-hydroxyethyl starch, a new plasma expander.
Mishler JM; Parry ES; Sutherland BA; Bushrod JR
Br J Clin Pharmacol; 1979 Jun; 7(6):619-22. PubMed ID: 88951
[TBL] [Abstract][Full Text] [Related]
19. [Morphological characteristics of the sequelae from the parenteral administration of solutions of hydroxyethyl starch].
Prostakova TM; Glasko EN; Khokhlova MP; Polushina TV
Arkh Patol; 1986; 48(7):43-7. PubMed ID: 2428336
[TBL] [Abstract][Full Text] [Related]
20. Influence of intravenous infusions of hydroxyethylstarch (HES) (MW 40,000 and 450,000) on the blood flow properties of healthy volunteers.
Ehrly AM; Landgraf H
Angiology; 1985 Jan; 36(1):41-4. PubMed ID: 2411169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
